Samar El‐Kalyoubi

556 total citations
35 papers, 435 citations indexed

About

Samar El‐Kalyoubi is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Samar El‐Kalyoubi has authored 35 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 19 papers in Molecular Biology and 5 papers in Toxicology. Recurrent topics in Samar El‐Kalyoubi's work include Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (10 papers). Samar El‐Kalyoubi is often cited by papers focused on Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (10 papers). Samar El‐Kalyoubi collaborates with scholars based in Egypt, Saudi Arabia and Indonesia. Samar El‐Kalyoubi's co-authors include Eman A. Fayed, Ahmed S. Abdel‐Razek, Wael A. Zordok, Ahmed Ragab, Mohamed G. Seadawy, Ola A. Abu Ali, Yousry A. Ammar, Ashraf S. A. El‐Sayed, Mohamed A. Tantawy and Ahmed A. Al‐Karmalawy and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and RSC Advances.

In The Last Decade

Samar El‐Kalyoubi

34 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar El‐Kalyoubi Egypt 13 313 196 50 33 29 35 435
Girish A. Hampannavar South Africa 12 428 1.4× 175 0.9× 53 1.1× 45 1.4× 37 1.3× 17 578
Chaitanya Mulakayala India 12 474 1.5× 194 1.0× 28 0.6× 41 1.2× 37 1.3× 16 601
Osama I. Alwassil Saudi Arabia 13 336 1.1× 163 0.8× 29 0.6× 24 0.7× 43 1.5× 27 439
Perwaiz Alam India 6 319 1.0× 109 0.6× 46 0.9× 29 0.9× 39 1.3× 7 423
Zakaria K. Abdel‐Samii Egypt 13 270 0.9× 176 0.9× 40 0.8× 42 1.3× 37 1.3× 25 364
Garima Verma India 4 310 1.0× 125 0.6× 22 0.4× 36 1.1× 37 1.3× 7 399
Žiga Skok Slovenia 11 226 0.7× 313 1.6× 54 1.1× 38 1.2× 22 0.8× 17 444
Carlos J. A. Ribeiro Portugal 13 230 0.7× 150 0.8× 65 1.3× 26 0.8× 16 0.6× 15 350
M. Kashi Reddy India 13 590 1.9× 243 1.2× 57 1.1× 38 1.2× 20 0.7× 19 661
Sonam Nirwan India 6 300 1.0× 112 0.6× 38 0.8× 40 1.2× 30 1.0× 11 396

Countries citing papers authored by Samar El‐Kalyoubi

Since Specialization
Citations

This map shows the geographic impact of Samar El‐Kalyoubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar El‐Kalyoubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar El‐Kalyoubi more than expected).

Fields of papers citing papers by Samar El‐Kalyoubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar El‐Kalyoubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar El‐Kalyoubi. The network helps show where Samar El‐Kalyoubi may publish in the future.

Co-authorship network of co-authors of Samar El‐Kalyoubi

This figure shows the co-authorship network connecting the top 25 collaborators of Samar El‐Kalyoubi. A scholar is included among the top collaborators of Samar El‐Kalyoubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar El‐Kalyoubi. Samar El‐Kalyoubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
El‐Magd, Nada F. Abo, et al.. (2024). Synthesis, In-Vitro, In-Vivo screening, and molecular docking of disubstituted aminothiazole derivatives and their selenium nanoparticles as potential antiparkinson agents. Journal of Molecular Structure. 1315. 138951–138951. 2 indexed citations
4.
El‐Kalyoubi, Samar, et al.. (2023). Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAFV600E. Pharmaceuticals. 16(5). 716–716. 11 indexed citations
5.
El‐Kalyoubi, Samar, Mohamed M. Khalifa, Mahmoud T. Abo‐Elfadl, et al.. (2023). Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2242714–2242714. 19 indexed citations
6.
El‐Kalyoubi, Samar, Samar S. Elbaramawi, Azizah M. Malebari, et al.. (2023). Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation. Bioorganic Chemistry. 136. 106560–106560. 7 indexed citations
7.
Hagras, Mohamed, Maghawry Hegazy, Ahmed A. El-Husseiny, et al.. (2023). Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors. Pharmaceuticals. 16(7). 966–966. 7 indexed citations
8.
Abdallah, Abdallah E., Hazem A. Mahdy, Samar El‐Kalyoubi, et al.. (2023). Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs. International Journal of Molecular Sciences. 24(15). 12416–12416. 14 indexed citations
9.
Hagras, Mohamed, Maghawry Hegazy, Ahmed A. El-Husseiny, et al.. (2023). New Thiouracil Derivatives As Histone Deacetylase Inhibitors and Apoptosis Inducers: Design, Synthesis and Anticancer Evaluation. Future Medicinal Chemistry. 15(12). 1019–1035. 3 indexed citations
11.
Farag, Basant, et al.. (2023). Design, Synthesis and Antitumor Activity of Novel pyran-functionalized Uracil Derivatives: Docking Studies. Future Medicinal Chemistry. 15(5). 421–436. 6 indexed citations
12.
Assy, Mohamed G., et al.. (2022). Synthesis, pharmacological evaluation, DFT calculation, and theoretical investigation of spirocyclohexane derivatives. Bioorganic Chemistry. 131. 106280–106280. 5 indexed citations
13.
El‐Kalyoubi, Samar, et al.. (2021). Synthesis, In Silico Prediction and In Vitro Evaluation of Antimicrobial Activity, DFT Calculation and Theoretical Investigation of Novel Xanthines and Uracil Containing Imidazolone Derivatives. International Journal of Molecular Sciences. 22(20). 10979–10979. 29 indexed citations
17.
El‐Kalyoubi, Samar, et al.. (2015). Novel 2-Thioxanthine and Dipyrimidopyridine Derivatives: Synthesis and Antimicrobial Activity. Molecules. 20(10). 19263–19276. 10 indexed citations
18.
Bayoumi, Ashraf H., et al.. (2012). One pot synthesis, DNA binding and fragmentation in vitro of new fused uracil derivatives for anticancer properties. Afinidad. 69(559). 224–228. 2 indexed citations
19.
Bayoumi, Ashraf H., et al.. (2012). Synthesis, DNA binding studies of new pyrimidothiazepine and pyrimidobenzothiazepine derivatives. Afinidad. 69(558). 144–149. 2 indexed citations
20.
El‐Sabbagh, Osama I., et al.. (2007). Synthesis, DNA Binding and Antiviral Activity of New Uracil, Xanthine, and Pteridine Derivatives. Archiv der Pharmazie. 340(1). 26–31. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026